Other OTC - Delayed Quote USD

MEDBRIGHT AI INVTS INC (MBAIF)

0.1030

+0.0039

(+3.94%)

At close: 2:44 PM EDT

Southern California Clinic Signs Multi-Year Deal for MedMatrix AI Platform

VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:Y30) today announced that Dermatology Institute & Skin Care Center (DISCC) has signed a 3 year contract to use the MedMatrix AI Platform, including all 5 product modules in their single clinic in Santa Monica, California. There are over 50,000 outpatient clinics in the US alone, and the Company is now focused on launching its US sales and market

GlobeNewswire 9 days ago
Rejuvenation Medical Group of Canada uses MedMatrix AI Reporter to Streamline Reporting and Improve Operations

VANCOUVER, British Columbia, March 19, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) today announced Rejuvenation medical group is using the commercial version of MedMatrix AI Reporter for centralized clinic operations reporting and dashboarding. The Company has a significant investment in the MedMatrix product suite. The MedMatrix AI Reporter provides data reporting from the MedMatrix AI analytics platform, a complete dash

GlobeNewswire last month
Southern California Clinic uses MedMatrix AI Market Expander to Launch Opening of New Clinic Locations

VANCOUVER, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) today announced that Dermatology Institute & Skin Care Center (DISCC) is using MedMatrix AI Market Expander, a product in which MedBright has a significant investment, to evaluate opening additional DISCC clinic locations in the Southern California region. The AI Market Expander tool assesses the potential demand in any given geographic mar

GlobeNewswire last month
MedBright AI Announces Investor Relations Agreement with Anthem Strategies Ltd.

VANCOUVER, British Columbia, March 06, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) announces that it has entered into an investor relations agreement (the “Agreement”) dated March 1, 2024 with Anthem Strategies Ltd. (“Anthem”), an arm’s length party to the Company. Pursuant to the Agreement, Anthem has agreed to provide investor relations and communications services to the Company, including digital and physical market

GlobeNewswire last month
MedMatrix Go-to-Market Pricing Announced for AI Product Suite Addressing US$726 Billion Market

VANCOUVER, British Columbia, March 05, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) today announced that MedMatrix, a product in which it has a significant investment, has announced the go-to-market pricing for both existing beta customers and new customers for its AI product suite. Last week, the MedMatrix AI five-feature product suite was announced to sell into the global outpatient clinic market. MedMatrix harnesses the

GlobeNewswire last month
MedMatrix Product Moves from Beta to Full Commercialization, Announces AI Product Suite

VANCOUVER, British Columbia, Feb. 27, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) today announced that MedMatrix, a product in which it has a significant investment, has completed its beta testing with its initial clients. As a result of the beta testing period, management has chosen a five-feature product suite to sell into the global outpatient facility market. MedMatrix harnesses the power of artificial intelligence to

GlobeNewswire last month
MedBright AI Announces Limmi Disease Insights Platform Being Used in University Hospital Setting to Improve Detection of Kidney Stone Disease Recurrence

VANCOUVER, British Columbia, Feb. 22, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF) is pleased to announce that the Limmi Disease Insights Platform is now being used in hospitals with an initial focus on kidney stone disease recurrence. Limmi is a key investment in Medbright’s AI Healthcare portfolio. UC San Diego Health is the first site that is utilizing Limmi’s Disease Insights Platform in a hospital setting. "We envision a futur

GlobeNewswire 2 months ago
MedBright AI Announces Closing of LIFE Offering for Gross Proceeds of Approximately $1.4 Million

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATESVANCOUVER, British Columbia, Feb. 09, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (CSE: MBAI) (OTCQB:MBAIF) (“MedBright” or the “Company”), is pleased to announce that it has closed the previously announced “commercially reasonable efforts” agency basis private placement offering of units (the “Units”) of the Company, for gross proceeds of $1,398,977.40 (the “Offering”). The Offer

GlobeNewswire 2 months ago
MedBright AI Investments Inc. Announces LIFE & Special Warrant Offering up to Approximately C$2,800,000

MedBright AI Investments Inc. (CSE: MBAI) (OTCQB: MBAIF) ("MedBright" or the "Company"), is pleased to announce that it has entered into an agreement with Canaccord Genuity Corp. to act as sole bookrunner and lead agent (the "Lead Agent") in connection with the Offering (as defined below). The Lead Agent, on behalf of a syndicate including Beacon Securities Limited and PI Financial Corp., will assist the Company on (a) a "commercially reasonable efforts" agency basis private placement offering (

CNW Group 2 months ago
MedBright AI’s MedMatrix to Expand Its AI Offerings for Cosmetic Marketing & Clinical Trial Analytics

VANCOUVER, British Columbia, Jan. 23, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) is pleased to announce that Rejuvenation, a prominent dermatology group and a leader in advanced dermatological care, is expanding its use of MedMatrix to include marketing for cosmetic treatments and clinical trial recruitment and data analysis. Rejuvenation’s extensive network includes 8 clinics spread across 3 provinces in Canada. The

GlobeNewswire 3 months ago
Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

NEW YORK, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Maxim Group LLC, a full-service investment banking, securities and wealth management firm, and M-Vest, a digital community built for issuers, investors, and thought leaders, present the 2024 Healthcare IT Virtual Conference. The conference will take place on Wednesday, January 24th, & Thursday, January 25th, 2024, starting at 9:00 a.m. ET. We will be presenting our 2024 Healthcare IT Virtual Conference. Allen Klee, Senior Research Analyst at Maxim Grou

GlobeNewswire 3 months ago
MedBright AI to Present at CEM Bahamas Small-Cap Conference and Maxim Group’s 2024 Healthcare IT Conference

VANCOUVER, British Columbia, Jan. 19, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) has announced today that they will be presenting at both the CEM Bahamas Small-Cap Conference, and Maxim Group’s 2024 Healthcare IT Conference in the upcoming week. CEM destination events link public and private issuers with top-tier investors through 1:1 meetings and networking at select venues across North America. MedBright AI is schedule

GlobeNewswire 3 months ago
MedBright AI Reaches US$100M in Total Clinic Revenue Under Contract with MedMatrix, the AI-Powered Data Analytics Platform

VANCOUVER, British Columbia, Jan. 18, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) has announced today that it has achieved its near term goal of total clinic revenue under management with MedMatrix, the AI-powered data analytics platform. 14 clinics in total across the US and Canada, representing an estimated US$100M in total clinic revenue1, are now using MedMatrix. “The adoption of MedMatrix has been extraordinary, w

GlobeNewswire 3 months ago
MedBright AI Investments Inc. Responds to OTC Markets Request on Recent Promotional Activity

VANCOUVER, British Columbia, Jan. 17, 2024 (GLOBE NEWSWIRE) -- MEDBRIGHT AI INVESTMENTS INC. (CSE: MBAI; OTCQB: MBAIF; FSE: 1V7) (“MedBright” or the “Company”) announces that it has been requested by OTC Markets Group Inc. (“OTC Markets”) to issue this statement about promotional activity concerning its common shares traded on the OTCQB market (operated by OTC Markets). On January 9, 2024, OTC Markets informed the Company that it became aware of certain promotional activities concerning the Comp

GlobeNewswire 3 months ago
MedBright AI Announces Rejuvenation Medical Group, a Large Canadian Clinic Group, as First International Customer for MedMatrix, the AI-Driven Data and Analytics Platform

9 Clinics, 3 Provinces, 21 Dermatologists, 5 Mohs Surgeons, 2 Plastic Surgeons, and 13 General PractitionersVANCOUVER, British Columbia, Jan. 09, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) is pleased to announce that Rejuvenation medical group, a prominent dermatology group and a leader in advanced dermatological care, has decided to adopt MedMatrix across all its clinics in Canada. Renowned for its cutting-edge dermatol

GlobeNewswire 3 months ago
MedBright AI Appoints Trevor Vieweg as Chief Executive Officer

VANCOUVER, British Columbia, Jan. 04, 2024 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright AI”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) is pleased to announce that Trevor Vieweg has joined MedBright AI as Chief Executive Officer effective January 4, 2024. Mr. Vieweg was previously Head of Product Development at Viasat (NASDAQ:VSAT) and later served as Chief Technology Officer of Sea Machines Robotics, a venture backed AI and robotics start-up. He is an investor in, and co

GlobeNewswire 3 months ago
MedBright AI Announces Closing of Investment in Limmi Healthcare AI Platform

VANCOUVER, British Columbia, Dec. 28, 2023 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) today announced that further to its press releases dated September 8, 2023 and October 17, 2023, Vinergy Acquisition Corp., a wholly owned US subsidiary of MedBright (“MB Acquisition Co.”), has issued 350 common shares of MB Acquisition Co. (the “MBAC Shares”) to Mentorhead Incorporated, a Delaware corporation, dba Limmi (“Limmi”)‎ pursuant

GlobeNewswire 3 months ago
MedBright AI Announces CareMEDICA, a Yale University School of Medicine Affiliated Clinic Group, as Beta Customer for MedMatrix, the AI-Driven Data and Analytics Platform

VANCOUVER, British Columbia, Dec. 14, 2023 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) today announced that CareMEDICA, a leading clinic group and provider of primary care services in Connecticut and South Florida has chosen to implement the beta version of MedMatrix into its practice. CareMEDICA has long-standing affiliations with Yale University School of Medicine and Quinnipiac University Medical Program. MedMatrix, an AI-p

GlobeNewswire 4 months ago
Emerging Markets Report: Building Trust

MedBright’s Recent Successes Send Signal that the Company is ExecutingAn Emerging Markets Sponsored Commentary ORLANDO, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) -- It’s been a minute since we last covered Medical/A.I. company MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7). It’s not because they haven’t been making significant moves. In our last editorial we noted the Company’s transformation to MedBright from Vinergy, a name change that made and makes s

GlobeNewswire 4 months ago
MedBright AI Announces Beta Customer for MedMatrix, the AI-Driven Data and Analytics Platform

VANCOUVER, British Columbia, Dec. 07, 2023 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “Company” or “MedBright”) (CSE:MBAI, OTCQB:MBAIF, FSE:1V7) is pleased to announce that the Dermatology Institute & Skin Care Center (“DISCC”), a leader in dermatologic services in Southern California, has chosen to implement MedMatrix to improve their clinic operations. MedMatrix is an industry leading AI-powered data analytics platform developed and operated by Healthcare Accretion AI, a Medbright

GlobeNewswire 4 months ago

Performance Overview

Return	MBAIF	S&P/TSX Composite index
YTD	-44.32%	+4.42%
1-Year	0.00%	+5.85%
3-Year	-85.44%	+14.57%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

MEDBRIGHT AI INVTS INC (MBAIF)

Southern California Clinic Signs Multi-Year Deal for MedMatrix AI Platform

Rejuvenation Medical Group of Canada uses MedMatrix AI Reporter to Streamline Reporting and Improve Operations

Southern California Clinic uses MedMatrix AI Market Expander to Launch Opening of New Clinic Locations

MedBright AI Announces Investor Relations Agreement with Anthem Strategies Ltd.

MedMatrix Go-to-Market Pricing Announced for AI Product Suite Addressing US$726 Billion Market

MedMatrix Product Moves from Beta to Full Commercialization, Announces AI Product Suite

MedBright AI Announces Limmi Disease Insights Platform Being Used in University Hospital Setting to Improve Detection of Kidney Stone Disease Recurrence

MedBright AI Announces Closing of LIFE Offering for Gross Proceeds of Approximately $1.4 Million

MedBright AI Investments Inc. Announces LIFE & Special Warrant Offering up to Approximately C$2,800,000

MedBright AI’s MedMatrix to Expand Its AI Offerings for Cosmetic Marketing & Clinical Trial Analytics

Maxim Group LLC to Host the 2024 Healthcare IT Virtual Conference on Wednesday, January 24th & Thursday, January 25th at 9:00 A.M. ET

MedBright AI to Present at CEM Bahamas Small-Cap Conference and Maxim Group’s 2024 Healthcare IT Conference

MedBright AI Reaches US$100M in Total Clinic Revenue Under Contract with MedMatrix, the AI-Powered Data Analytics Platform

MedBright AI Investments Inc. Responds to OTC Markets Request on Recent Promotional Activity

MedBright AI Announces Rejuvenation Medical Group, a Large Canadian Clinic Group, as First International Customer for MedMatrix, the AI-Driven Data and Analytics Platform

MedBright AI Appoints Trevor Vieweg as Chief Executive Officer

MedBright AI Announces Closing of Investment in Limmi Healthcare AI Platform

MedBright AI Announces CareMEDICA, a Yale University School of Medicine Affiliated Clinic Group, as Beta Customer for MedMatrix, the AI-Driven Data and Analytics Platform

Emerging Markets Report: Building Trust

MedBright AI Announces Beta Customer for MedMatrix, the AI-Driven Data and Analytics Platform

Performance Overview